Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04081389. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01201265. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04095689. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04690855. IPD Sharing: NO. Countries: 1. Publications: 0.
Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03130439. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body
ClinicalTrials.gov study NCT05198843. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
ClinicalTrials.gov study NCT03542175. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)
ClinicalTrials.gov study NCT01216111. IPD Sharing: Not stated. Countries: 0. Publications: 8.
Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT02719691. IPD Sharing: NO. Countries: 1. Publications: 0.
Estrogen for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01083641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04461600. IPD Sharing: NO. Countries: 5. Publications: 0.
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT02883062. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes
ClinicalTrials.gov study NCT06833723. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT03057600. IPD Sharing: NO. Countries: 1. Publications: 0.
Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT02457910. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Sprea
ClinicalTrials.gov study NCT03098550. IPD Sharing: NO. Countries: 9. Publications: 0.
A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01094184. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT03121352. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT03872388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02489448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.